Subclinical Atrial Fibrillation and Anticoagulation : Weighing the Absolute Risks and Benefits
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:149 |
---|---|
Enthalten in: |
Circulation - 149(2024), 13 vom: 26. März, Seite 989-992 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Patel, Siddharth M [VerfasserIn] |
---|
Links: |
---|
Themen: |
5Q7ZVV76EI |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 03.04.2024 published: Print-Electronic CommentOn: Circulation. 2023 Nov 12;:. - PMID 37952187 Citation Status MEDLINE |
---|
doi: |
10.1161/CIRCULATIONAHA.123.067919 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370166973 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370166973 | ||
003 | DE-627 | ||
005 | 20240404235153.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240327s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1161/CIRCULATIONAHA.123.067919 |2 doi | |
028 | 5 | 2 | |a pubmed24n1364.xml |
035 | |a (DE-627)NLM370166973 | ||
035 | |a (NLM)38527139 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Patel, Siddharth M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Subclinical Atrial Fibrillation and Anticoagulation |b Weighing the Absolute Risks and Benefits |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 03.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: Circulation. 2023 Nov 12;:. - PMID 37952187 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Editorial | |
650 | 4 | |a Comment | |
650 | 4 | |a Editorials | |
650 | 4 | |a anticoagulants, hemorrhage | |
650 | 4 | |a atrial fibrillation | |
650 | 4 | |a ischemic stroke | |
650 | 4 | |a risk | |
650 | 7 | |a Warfarin |2 NLM | |
650 | 7 | |a 5Q7ZVV76EI |2 NLM | |
650 | 7 | |a Anticoagulants |2 NLM | |
700 | 1 | |a Ruff, Christian T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Circulation |d 1950 |g 149(2024), 13 vom: 26. März, Seite 989-992 |w (DE-627)NLM000039020 |x 1524-4539 |7 nnns |
773 | 1 | 8 | |g volume:149 |g year:2024 |g number:13 |g day:26 |g month:03 |g pages:989-992 |
856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCULATIONAHA.123.067919 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 149 |j 2024 |e 13 |b 26 |c 03 |h 989-992 |